MGRO — MustGrow Biologics Cashflow Statement
0.000.00%
Last trade - 00:00- CA$35.89m
- CA$35.55m
- CA$8.29m
Annual cashflow statement for MustGrow Biologics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.06 | -5.57 | -0.677 | -4.89 | -7.26 |
| Depreciation | |||||
| Non-Cash Items | 0.324 | 1.7 | 0.926 | 1.47 | 2.22 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.329 | 0.604 | -0.544 | -0.164 | -0.075 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -2.41 | -3.26 | -0.295 | -3.58 | -5.06 |
| Other Investing Cash Flow Items | — | — | — | — | -1.5 |
| Acquisition of Business | |||||
| Cash from Investing Activities | — | — | — | — | -1.5 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.72 | 0.654 | 0.096 | -0.241 | 4.48 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.31 | -2.6 | -0.199 | -3.82 | -2.08 |